| Literature DB >> 24621342 |
Antonina A Votintseva1, Rowena Fung, Ruth R Miller, Kyle Knox, Heather Godwin, David H Wyllie, Rory Bowden, Derrick W Crook, A Sarah Walker.
Abstract
BACKGROUND: Staphylococcal protein A (spa) is an important virulence factor which enables Staphylococcus aureus to evade host immune responses. Genotypes known as "spa-types", based on highly variable Xr region sequences of the spa-gene, are frequently used to classify strains. A weakness of current spa-typing primers is that rearrangements in the IgG-binding region of the gene cause 1-2% of strains to be designated as "non-typeable".Entities:
Mesh:
Substances:
Year: 2014 PMID: 24621342 PMCID: PMC4007515 DOI: 10.1186/1471-2180-14-63
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Scheme of the-gene with annealing sites for the novel spaT3-F primer and standard primers. Notes: black arrows indicate five annealing sites for spaT3-F primer; grey arrow indicates annealing site for 1095 F standard primer; white arrow indicates annealing site for 1517R standard primer; figures represent distance between the beginning of spaT3-F primer and the beginning of Xr region. Spa-gene: s – signal sequence, E, D, A, B, C – IgG-binding domains, X – region which lacks IgG-binding activity and consists of repetitive region (Xr) and C-terminal region (Xc).
Figure 2Amplification of-locus with novel primers spaT3-F/1517R from the samples with rearrangements in the-gene. A control sample does not have any rearrangements in the spa-gene and shows five PCR bands according to five annealing sites of the spaT3-F primer, including a faint band in the region of 500 bp. DelH shows one thick band most likely consisted of two merged bands from the two spaT3-F annealing sites that had been brought close together by the deletion. InsC2 has a bright band (600 bp) most likely consisted of two PCR products due to insertion of additional spaT3-F annealing site. The rest of the samples display the number of bands according to the types of rearrangements (Figure 3). Amplification of these samples with the standard spa-typing primers 1095 F/1517R will give no bands for the samples with delE and delG, which affect the position of 1095 F standard primer. For the rest of the sample PCR will generate a single band (double band for the insC2) located at a variable position on the ladder depending on the number of repeats within Xr region of each sample.
Figure 3Scheme of the rearrangements identified in the IgG-binding domains of-gene in samples from Oxfordshire. Notes: The insertions are indicated by grey rectangles. The deletions indicated by dotted thin lines. Black arrows indicate annealing sites for spaT3-F novel primer; grey arrows indicates annealing site for 1095 F standard primer; white arrow indicates annealing site for 1517R standard primer. Grey rectangles with arrows indicate insertions with additional binding sites for primers. Panel (a) indicates deletions found only in community samples, panel (b) indicates deletions found only in inpatient samples and panel (c) indicates deletions found both in community and inpatient samples. Spa gene: s – signal sequence, E, D, A, B, C sequences encoding IgG-binding domains, X - region which lacks IgG-binding activity and consists of repetitive region (Xr) and C-terminal region (Xc). Asterisk indicates deletion previously described by Baum et al., 2009. Dagger indicates deletions/insertions leading to strains being designated non-typeable using the standard primers.
isolates with and without different types of rearrangement in the -gene in community and inpatient samples: formerly non-typeable isolates
| | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total | 3,905 | 100% | 442 | 100% | 2,205 | 100% | 1,273 | 100% |
| Pure without deletions/insertions or with hidden deletions3 | 3647 | 93.4% | 334 | 75.6% | 2055 | 93.2% | 1150 | 90.3% |
| Mixed with or without deletions and/or rearrangements4 | 258 | 6.6% | 108 | 24.4% | 150 | 6.8% | 123 | 9.7% |
| Formerly non-typeable: i.e. pure with rearrangements affecting standard | 72 | 1.8% (from total) | 8 | 1.8% (from total) | 14 | 0.6% (from total) | 9 | 0.7% (from total) |
| 27.9% (from 12 picks) | 7.4% (from12 picks) | 9.3% (from 12 picks) | 7.3% (from 12 picks) | |||||
1 – nasal swabs collected from individuals recruited in 5 GP practices in Oxfordshire.
2 – nasal swabs from individuals admitted to the adult ITU, Gerontology and Trauma wards of the Oxford University Hospitals NHS Trust.
3 – indicates where all samples from an individual were pure using our spa-typing protocol (i.e. were without deletions/insertions or only with hidden deletions) versus any sample did not fall into this category.
4 –subjected to 12 single colony picks, i.e. 12 sub-colonies analysed from each sample.
isolates with and without different types of rearrangement in the -gene in community and inpatient samples: isolates with hidden deletions
| Total strains without deletions/insertions or with only hidden deletions investigated | 99 | 100% | 97 | 100% |
| Hidden deletions found | 11 | 11% | 11 | 11% |
Note: Hidden deletions were found in 16% (5/32) of S. aureus strains from 16% (5/31) individuals in the community and in 9% (6/67) strains from 9% (6/66) hospital in patients with bacteraemia (p = 0.33); pooled data are therefore presented.
-typing of strains from a single individual AE with two sets of primers: standard primers 1095 F/1517R and novel primers spaT3-F/1517R
| AE-0 | t230 | MST1 | t230/ |
| AE-1 | non-typable | ||
| AE-2 | t230 | MST | t230/ |
| AE-4 | t230 | MST | t230 |
| AE-6 | t230 | MST | t230/t528 |
| AE-8 | t008 | MST | t008/ |
| AE-10 | t230 | MST | t230 |
| AE-12 | t230 | MST | t230 |
| AE-14 | t230 | MST | t230 |
1mixed sequence traces; 2spa-types in bold have delE and could not be typed with standard primers; spa-repeats:
t230: 08-16-02-16-34.
t571: 08-16-02-25-02-25-34-25.
t008: 11-19-12-21-17-34-24-34-22-25.
t012: 15-12-16-02-16-02-25-17-24-24.
t528: 04.
Individuals who acquired a deletion in the -gene during their hospital admission
| BC | 30/01/2011 | MSSA | t298 | |
| BC | 08/02/2011 | MSSA | delG-insB | |
| BD | 14/04/2011 | MSSA | t571 | |
| BD | 19/04/2011 | MSSA | delG-insB | |
| BD | 26/04/2011 | MSSA | delG-insB | |
| BE-a1 | 20/06/2011 | MSSA | t179 | |
| BE-g2 | 20/06/2011 | MSSA | t179 | |
| BE-n3 | 20/06/2011 | MSSA | t179/t078 | |
| BE-th4 | 20/06/2011 | MSSA | t179/t078 | |
| BE | 05/07/2011 | MSSA | t179/t078 | |
| BE | 12/07/2011 | MSSA | t179/ | delE |
| BE | 20/07/2011 | MSSA | t179/ | delE |
1–4body sites swabs: a – axilla, g – groin, n – nose, th – throat; all other swabs are nasal swabs; spa-types in bold acquired deletion that affects binding site for standard forward spa-typing primer.
-types and groups in which deletions/insertions in the -gene were observed
| Group 1 | | 7 (21%) | | | 7/20 (35%)* |
| t571 | 08-16-02-25-02-25-----------34-25 | 6 (18%) | | delG-insB(5); delE(1) | 6/19 (32%) |
| t3085 | 08-16-02-25-02-25-34-25-34-25 | 1 (3%) | | delE (1) | 1/1 (100%) |
| Group 2 | | 9 (27%) | | | 7/188 (4%)* |
| t021 | 15-12------16-02-16---------------02-25-17-24-------------- | 4 (12%) | delD(1) | insC2(3) | 3/57 (5%) |
| t298 | 15-12------16-02-----------------------------17-24-------------- | 1 (3%) | | delG-insB (1) | 1/5 (20%) |
| t10173 | 15-12-02-16-02------25-17-25-02-25-17-24-24--------- | 1 (3%) | | insC2 (1) | 1/1 (100%) |
| t012 | 15-12------16-02-16---------------02-25-17-24-24--------- | 2 (6%) | | delE (1); insC2 (1) | 2/123 (2%) |
| t6803 | 15-12------16-02-16---------------02-25-17-24-24-17-24 | 1 (3%) | delD-insA (1) | | 0/2 (0%) |
| Group 3 | | 3 (9%) | | | - |
| t084 | 07-23-12-34-34-12-12-23-02-12-23 | 1 (3%) | delH (1) | | - |
| t085 | 07-23-12-34-34-12-----23-02-12-23 | 2 (6%) | delD (1); delA (1) | | - |
| Group 4 | | 4 (12%) | | | 3/74 (4%)* |
| t280 | 04--------------------20-17-12-12-17------------- | 1 (3%) | | delG-insB (1) | 1/4 (25%) |
| t227 | 04-----------------------------12-12-17------------- | 1 (3%) | delD (1) | | 0/3 (0%) |
| t078 | 04-21a-12b-41c-20-17-12-12-17------------- | 1 (3%) | | delE (1) | 1/26 (4%) |
| t216 | 04----------20-17-20-17------------31d-16e-34f | 1 (3%) | | delG-insB (1) | 1/41 (2%) |
| Group 5 | | 3 (9%) | | | 1/92 (1%)* |
| t032 | 26-23-23-13-23-31-29-17-31-29-17-25-17-25-16-28 | 2 (6%) | delD (1) | delE (1) | 1/79 (1%) |
| t223 | 26-23-----13-23-------------------05g-17-25-17-25-16-28 | 1 (3%) | delD (1) | | 0/13 (0%) |
| Singletons | | 7 (21%) | | | - |
| t213 | 07-23-12-21-24-33-22-17 | 3 (9%) | delD (3) | | - |
| t6792 | 08-16-02-16-17-13-17-13-17-16-34 | 1 (3%) | delD (1) | | - |
| t6417 | 14-44-13-12-17-13-12-17-17-17-23-18 | 1 (3%) | dell (1) | | - |
| t530 | 11-19-12-21-17-34-24-34-16 | 1 (3%) | | delE (1) | 1/3 (33%) |
| t7960 | 299-25-17-17-16-16-16-16 | 1 (3%) | delI-insC1 (1) | | - |
| Total | 33 (100%) |
* P < 0.0001 comparing four groups of spa-types and the singleton with rearrangements affecting spa-typing (5 × 2 Fisher’s exact test).
21a repeat differing in one base from repeats 12 and 20.
12b repeat differing in two bases from repeats 20.
41c repeat differing in one base from repeat 17.
31d repeat differing in two bases from repeat 16.
16e repeat differing in one base from repeat 17.
34f repeat differing in two bases from repeats 12 and 20.
05g repeat differing in one base from repeat 29.